PostDoc fellow
PhD
+39 02 6448 8177
eleonora.pozzi@unimib.it
Born in 1991. She graduated in Biotechnology (Bachelor’s degree) in 2013 and in Biology (Master degree cum laude) in 2016 at the University of Milano-Bicocca. In January 2020, she received her PhD in Neuroscience.
Since 2014 she has been collaborating in in vivo research projects on Chemotherapy-Induced Peripheral Neurotoxicity at Experimental Neurology Unit (University of Milano-Bicocca), where now she works as postdoctoral researcher.
Her main expertise is in the development and use of in vivo experimental models to study the peripheral neuropathies.
She is author of several scientific papers on International peer-reviewed journals and an active member of Italian and international scientific associations.
RESEARCH INTERESTS
- Preclinical assessment of chemotherapy-induced peripheral neurotoxicity (CIPN)
- Neuroprotection studies in chemotherapy-induced peripheral neuropathies (CIPN) models
- Study of molecular mechanisms involved in chemotherapy-induced peripheral neurotoxicity (CIPN)
MOST RELEVANT PUBLICATIONS
- Pozzi E., Alberti P. Chapter “Management of side-effects in the personalized medicine era: chemotherapy induced peripheral neuropathy”. Book “Pharmacogenomics in Drug Discovery and Development (3rd Edition); Springer Nature, USA 2022. Accepted
- Bloomingdale P., Meregalli C., Pollard K., Canta A., Chiorazzi A., Fumagalli G., Monza L., Pozzi E., Alberti P., Ballarini E., Oggioni N., Carlson L., Liu W., Ghandili M., Ignatowski T., Lee K., Moore M., Cavaletti G., Mager D. Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain. Front. Pharmacol., 19 January 2022. DOI: 10.3389/fphar.2021.817236
- Meregalli A., Monza L., Chiorazzi A., Scali C., Guarnieri C., Fumagalli G., Alberti P., Pozzi E., Canta A., Ballarini E., Rodriguez-Menendez V., Oggioni N., Cavaletti G., Marmiroli P. Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity. Int J Mol Sci. 2021 Jan 21;22(3):1058. DOI: 10.3390/ijms22031058.
- Pozzi E., Fumagalli G., Chiorazzi A., Canta A., Cavaletti G. Genetic factors influencing the development of vincristine-induced neurotoxicity. Expert Opin Drug Metab Toxicol. 2021 Feb;17(2):215-226. DOI 10.1080/17425255.2021.1855141.
- Pozzi E., Fumagalli G., Chiorazzi A., Canta A., Meregalli C., Monza L., Carozzi VA., Oggioni N., Rodriguez-Menendez V., Cavaletti G., Marmiroli P. The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity. Exp Neurol. 2020 Dec;334:113458. DOI: 10.1016/j.expneurol.2020.113458.
Find out more on